Stock Ticker

  • Loading stock data...

Abbott (NYSE: ABT) Announces New Study To Offer Treatment Alternatives For AFib And Heart Failure Patients

Abbott (NYSE: ABT) has announced a new study to improve treatment for patients battling heart failure and atrial fibrillation (AFib). This will be the first of its kind study to offer a unique insight into an effective treatment for people suffering from both heart failures and AFib. This disease combination has significant challenges to physicians.  […]